Intern
Chair for Drug Formulation and Delivery

News

Great job, Niklas!

12.12.2022

On 12 December 2022, Niklas Hauptstein completed his PhD with the defense of his dissertation entitled "Site directed molecular design and performances of Interferon-α2a and Interleukin-4 bioconjugates with PEG alternative polymers". Congratulations!

 

 

Mehr

Well done, Jonas!

07.12.2022

On 07 December 2022, Jonas Schlauersbach completed his PhD with the defense of his dissertation entitled "Bile-drug-excipient interplay". Congratulations!

 

 

Mehr

ChemSyStM 2022

06.12.2022

On December 6th, Benedikt, Debora, Eduardo, Kristin, Rafael and Prisca each presented a poster on their research projects at the ChemSyStM 2022 in Würzburg. Prisca was awarded with the prize for the best poster in the field “Food chemistry and Pharmacy”. Many thanks to the JCF Würzburg for organizing this lively event!

Mehr

Congratulations to Jonas, Josef, & team! They developed an algorithm predicting bile and lipid interaction of poorly water-soluble drugs! Hopefully, it might complement/precede vastly complex experiments which are currently required along these lines!

Mehr

CRS Aachen

08.04.2022

Four of our PhD students attended the 2022 meeting of the local chapters of the controlled release society (Germany, BeNeLux, France) in Aachen. Our team members contributed to the stimulating conference with three oral talks and one elevator pitch, with Eduardo Merino Asumendi and Simon Hanio being awarded for the conference’s best talk and elevator pitch, respectively. Many thanks to Prof. Lammers and his team for the excellent organization.

Mehr

Review on IFN drugs

24.02.2022

Congratulations to Niklas Hauptstein & team for their review ”Bioconjugation strategies and clinical implications of Interferon-bioconjugates“, published in the European Journal of Pharmaceutics and Biopharmaceutics. The article reviews available IFN drugs, their field and route of application, while also outlining available and future strategies for bioconjugation to further optimize pharmaceutical and clinical performances of all three available IFN classes.

Mehr